spacer
home > epc > Winter 2001
PUBLICATIONS

European Pharmaceutical Contractor

epc
Winter 2001
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. EPC provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of EPC
   
Text
PDF
bullet
introduction
In his Editor's Letter, Dr Graham Hughes summarises the articles in this 'new-look' issue of EPC  
view
bullet
Marketplace & Business
When choosing a CRO, there should be a balanced assessment of all potential factors. Andy Broadhurst, Research Director at Heart Research, UK, discusses Outsourcing Your Clinical Trial - The Search for Added Value  
view
Dr David Cavalla, CEO of Arachnova Ltd considers the benefits of the virtual company (increased flexibility and reduced exposure to infrastructure costs) in Outsourcing R&D - The Value of Virtuality  
view
bullet
Clinical Trials
In Automating the Preparation of Test Articles and Clinical Trial Supplies, Imogen Gill, David Edwards, Bruce Macmichael, and Ian Smith of Meridica Limited, UK, explain how automation of preclinical and clinical trial supplies can provide a step towards increasing speed to market  
For anyone working in clinical trials, Yugoslavia is not the first place that springs to mind. However, Helen Springford, Director of European Business Development, and Pavle Vukojevic, Clinical Research Associate for Pharm-Olam International, highlight the country's potential in Yugoslavia - A Re-Emerging Market for Clinical Trials  
view
bullet
Legal & Regulatory
Whilst the Internet offers opportunities to develop brands, it also harbours many dangers for pharmaceutical companies. Clarke Graham, Partner at Marks & Clerk, London, investigates the effect of the Internet on intellectual property in A Shot in the Arm for the Pharmaceutical Industry - Protecting Pharmaceutical Brands and the Impact of the Internet  
view
bullet
Drug Discovery, Development & Delivery
In The Trojan Horse of Oncology - The Role of Stealth Drug Delivery, Dr Peter Cheverton MBChB, MMed Rad(T), Director of Oncology for Daiichi Pharmaceuticals UK Ltd, looks at the latest methods available to oncologists in the fight against cancer  
view
Dr Linda Potgieter, Senior Director at FARMOVS-PAREXEL, South Africa, assesses possible solutions and suggestions to promote the harmonisation of bioequivalence and bioavailability issues across all global CROs, in Practical Issues Regarding Bioequivalence Studies  
view
The optimisation of ovarian carcinoma therapy is outlined in conversation with Dr Uwe Wagner, Deputy Medical Director and Lecturer at the University of Tьbingen's Gynaecological Hospital, in The Monoclonal Anti-Idiotype Antibody ACA 125 - A Breakthrough for Ovarian Cancer  
view
Dr Graham Hughes, Editor of EPC, discusses the aims of the New Safe Medicines Faster initiative, launched by the European Federation of Pharmaceutical Sciences in 2000  
view
bullet
Patient Recruitment
Jane Baguley, Director of Business Management Services for Quintiles Europe reviews the options available to maximise the chance of achieving patient recruitment objectives, in The Challenge of Patient Recruitment  
view
bullet
COUNTRY FOCUS - JAPAN
In A Competitive Analysis of the Japanese Pharmaceutical and Biotechnology Industries, Anil Vaidya, Export Promoter - Japan Unit, Trade Partners UK, explains how despite the fact that Japan is the second largest pharmaceutical market in the world, Japanese pharmaceutical companies are concerned about their future prospects  
view
Given that SMOs are a fairly new phenomenon even in the West, Japanese sponsors could be excused for not acknowledging the contribution that these organisations can make to clinical plans. Tristan Brittain-Dissont, Commercial Director at Intercern Clinical Research Networks, discusses SMOs - Creating a New Outsourcing Strategy for Japanese Pharmaceutical Companies  
view
bullet
SPECIAL FEATURE: CENTRAL LABORATORIES
In Using Polymer Beads to Assist Solution Phase Synthesis, Andrew Coffey PhD, Solid Phase Synthesis Support Product Manager at Polymer Laboratories Ltd, considers the real advantages to be gained in utilising compounds tethered to polymer beads  
view
EPC's Editor, Dr Graham Hughes, reviews the latest DIA meeting which was held at the Royal Park at Evian-les Bains, in An Analysis of the Future - The Bloodless Coup  
view
bullet
LABS & Logistics
Dr Drew Kilpatrick, Associate Director of Project Management at Inveresk Research and Peter Crespin of 'The Writers Bureau', highlight the benefits of using courier integration systems for the more efficient management of logistic information, in Improving Clinical Trial Management - Moving Shipping Logistics Online  
view
bullet
DATA MANAGEMENT
Technological advances in IVRS have led to the efficient management of multiple facets of clinical trial research. James S. Primerano Jr, Business Development Manager with Interactive Clinical Technologies (ICTI), puts forward Integrative Protocol Design Considerations Employing Interactive Voice Response System (IVRS) Technology  
view
Jeffrey Klofft, Vice President/General Manager of Data Management Products, and Paul Bleicher, Chairman and Chief Science Officer at Phase Forward Incorporated, investigate the next stage in the evolution of the clinical trial infrastructure in e-CDM - The Complete Solution for Clinical Data Management  
view
In clinical trials, paper-based systems can lead to time delays and quality problems. Maryann Lombardo, an Analyst at Datamonitor, recommends the electronic alternative in Electronic Data Capture - Achieving the Promise of More Efficient Trials  
view
The construction of an EDC library is of primary importance to achieving a successful project. Linda Mook and Frank Zweerus, Directors of Product Management at Araccel, explain why in The Value of e-Libraries in EDC Scale-Up Scenarios  
view
In Electronic Data Capture - Paving the Way for Successful Clinical Trials, Wolfgang J. Oestreich, Managing Director of Dr Oestreich + Partners, outlines the advantages of EDC over the more traditional paper-based systems  
view
Douglas Bain, Director of TEAMworks, UK, explains how e-CDM - The Next Generation of Clinical Research Information Management Systems, can add value to the clinical trials process  
view
   
spacer



Published quarterly in
February, May,
August and November

News and Press Releases

Arquer Diagnostics Appoints Nadia Whittley as CEO


More info >>

White Papers

Value-Added Processing and Quality By Design Principles Help Meet High-Quality Demands

West Pharmaceutical Services, Inc.

The current pharmaceutical market has faced a variety of challenges, including increasing expectations for quality from end-users and regulatory agencies driven by concern for patient safety. While pharmaceutical companies are working to assure that new quality and compliance paradigms are met, a balance must be achieved between the reality of managing costs in an effort to provide a product that meets the requirements of payers along with facilitating profitability in order to continue adequate business reinvestment.
More info >>

Industry Events

6th Annual Cancer Vaccines Conference

27-28 September 2017, Copthorne Tara Hotel, London UK

Cancer Vaccines 2017: Overcoming hurdles to cancer immune response: Cell therapies, vaccine development and combination therapies. SMi Group is thrilled to present the 6th annual Cancer Vaccines conference, taking place on 27th & 28th September 2017 in Central London, UK. Overcoming hurdles to cancer immune response: Cell therapies, vaccine development and combination therapies.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement